CT-based Abdominal Adipose Tissue Area Changes in Patients Undergoing Adrenalectomy Due to Cushing’s Syndrome and Non-functioning Adenomas

Abstract

Background The majority of Cushing’s syndrome (CS) cases constitute patients with functional adrenal adenomas. In adrenal CS, visceral adipose tissue (VAT) area, VAT/subcutaneous adipose tissue (SAT), and VAT/total adipose tissue (TAT) ratios are expected to decrease in response to adrenalectomy, although no change is expected in non-functioning adrenal adenomas (NFA).

Objective To evaluate the changes in VAT, SAT, TAT areas and VAT/SAT, VAT/TAT ratios using computed tomography (CT) in patients who underwent adrenalectomy due to adenomas.

Methods Preoperative and postoperative CT of 32 patients (16 with CS and 16 with NFA) were retrospectively evaluated. The VAT, SAT, TAT areas were obtained from CT at the level of L1–2 intervertebral disc space, and the VAT/SAT, VAT/TAT ratios were calculated. The postoperative parameter changes in both groups were evaluated compared to the preoperative values. The level of statistical significance was considered as p<0.05.

Results The time interval between preoperative and postoperative CT measurements were 10.37 months (6–17) in CS and 9.75 months (7–15) in NFA groups (p=073). Preoperative CT indicated that the patients with CS had larger VAT and TAT areas (p=0.03, p=0.02) but SAT remained unchanged (p=0.08). However, postoperative CT revealed that there was no difference between the two groups in terms of VAT, TAT, and SAT areas (p=0.87, p=0.36, p=0.14). Postoperatively, in patients with CS, there was a decrease in VAT and TAT areas (p=0.01 for both) and VAT/SAT and VAT/TAT ratios (p=0.03, p=0.02) but SAT remained unchanged (p=0.10). In patients with NFA, no change was detected in the postoperative SAT, TAT, and VAT areas (p=0.12, p=0.40, p=0.99) or the VAT/SAT and VAT/TAT ratios (p=0.38, p=0.62).

Conclusions Adrenalectomy is an effective treatment method leading to a decrease in the VAT, TAT areas, and VAT/SAT and VAT/TAT ratios in patients with cortisol producing adrenocortical adenoma. Thus, CT facilitates quantitative demonstration of the changes while evaluating the response of these patients to treatment.

Key words

Adrenal adenoma - Cushing’s syndrome - computed tomography - VAT - SAT - TAT

Publication History

Received: 17 March 2021
Received: 07 June 2021

Accepted: 07 July 2021

Article published online:
06 August 2021

• References

• 1 Mosconi C, Vicennati V, Papadopoulos D. et al Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT Predictive Score. Am J Roentgenol 2017; 209: 122-129
• 2 Comlekci A, Yener S, Ertilav S. et al Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010; 37: 40-46
• 3 Elbanan MG, Javadi S, Ganeshan D. et al Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom Radiol (NY) 2020; 45: 905-916
• 4 Al-Thani H, El-Menyar A, Al-Sulaiti M. et al Adrenal mass in patients who underwent abdominal computed tomography examination. N Am J Med Sci 2015; 7: 212-219
• 5 Kim J, Bae KH, Choi YK. et al Clinical characteristics for 348 patients with adrenal incidentaloma. Endocrinol Metab 2013; 28: 20-25
• 6 Low G, Sahi K. Clinical and imaging overview of functional adrenal neoplasms. Int J Urol 2012; 19: 697-708
• 7 Yener S. Metabolic and cardiovascular impact of non-functioning adrenal adenomas: a clinical dilemma. Eur J Intern Med 2013; 24: 520-524
• 8 Barzon L, Sonino N, Fallo F. et al Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149: 273-285
• 9 Mahmood E, Anastasopoulou C. Adrenal Adenoma. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2021
• 10 Yener S, Baris M, Peker A. et al Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up. Clin Endocrinol (Oxf) 2017; 87: 425-432
• 11 Rockall AG, Sohaib SA, Evans D. et al Computed tomography assessment of fat distribution in male and female patients with Cushing’s syndrome. Eur J Endocrinol 2003; 149: 561-567
• 12 Carr DB, Utzschneider KM, Hull RL. et al Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094
• 13 Goodpaster BH, Krishnaswami S, Harris TB. et al Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-783
• 14 Fassnacht M, Arlt W, Bancos I. et al Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2016; 175: 1-34
• 15 Hong N, Lee J, Ku CR. et al Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism. Clin Endocrinol 2019; 90: 267-276
• 16 Kuk JL, Church TS, Blair SN. et al Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?. Diabetes Care 2006; 29: 679-684
• 17 Yoshizumi T, Nakamura T, Yamane M. et al Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-286
• 18 Pecori Giraldi F, Moro M, Cavagnini F. Study group on the hypothalamo-pituitary-adrenal axis of the Italian Society of Endocrinology. Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab 2003; 88: 1554-1558
• 19 Zhou J, Zhang M, Bai X. et al Demographic characteristics, etiology, and comorbidities of patients with Cushing's syndrome: A 10-year retrospective study at a large general hospital in China. Int J Endocrinol 2019; 2019: 7159696
• 20 Wengander S, Trimpou P, Papakokkinou E. et al The incidence of endogenous Cushing’s syndrome in the modern era. Clin Endocrinol (Oxf) 2019; 91: 263-270
• 21 Giordano R, Marinazzo E, Berardelli R. et al Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol 2010; 162: 779-785
• 22 Debono M, Prema A, Hughes TJ. et al Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma. J Clin Endocrinol Metab 2013; 98: 2383-2391
• 23 Stratakis CA. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome). Endocr Dev 2008; 13: 117-132
• 24 Larsson B, Svärdsudd K, Welin L. et al Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-1444
• 25 Shahraki M, Shahraki T, Pourghasem GB. etal Central obesity and coronary heart disease risk factors in referral outpatients to zahedan cardiology clinic, iran. Int J High Risk Behav Addict 2012; 1: 79-83
• 26 Borkan GA, Gerzof SG, Robbins AH. et al Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36: 172-177